GenIBET Biopharmaceuticals Overview
- Founded
- 2006
- Status
- Acquired/Merged
- Employees
- 75
- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 2
GenIBET Biopharmaceuticals General Information
Description
Provider of contract development and manufacturing services intended for research groups, biotech and pharma companies. The company offers specialized microbial, cell culture and viral-process development and current good manufacturing practice (cGMP) services, providing clients with safe and reliable products that support them in building the therapies of the future.
Contact Information
Website
www.genibet.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- Edifício da BPU do iBET
- Avenida da República Quinta do Marquês
- Oeiras, 2780-157
- Portugal
+351 21 000 0000
GenIBET Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore GenIBET Biopharmaceuticals‘s full profile, request access.
Request a free trialGenIBET Biopharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of contract development and manufacturing services intended for research groups, biotech and pharma companies.
Other Pharmaceuticals and Biotechnology
Oeiras, Portugal
75
As of 2022
000000000000
0000000
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo con
0000000000000
Basel, Switzerland
00
As of 0000
000000&0
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialGenIBET Biopharmaceuticals Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 0000000 | Corporate Backed or Acquired | Basel, Switzerland | 00 | 000000&0 |
GenIBET Biopharmaceuticals Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Raquel Fortunato Ph.D | Chief Executive Officer & Board Member | ||
| João Lopes | Co-Founder & Board Member | ||
| Ulrike Lemke | Chairman & Board Member |
GenIBET Biopharmaceuticals Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 00000 00.0 | Self | Board Member | 000 0000 |
| 00ã0 00000 | GenIBET Biopharmaceuticals | Co-Founder & Board Member | 000 0000 |
| 000000 000000000 00.0 | GenIBET Biopharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
| 000 000000000 | GenIBET Biopharmaceuticals | Board Member | 000 0000 |
| 000000 00000 | Self | Chairman & Board Member | 000 0000 |
GenIBET Biopharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGenIBET Biopharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore GenIBET Biopharmaceuticals‘s full profile, request access.
Request a free trial